Abstract

Breast tissue engineering has the potential to add an additional clinically relevant breast reconstruction option following breast cancer surgery. The current strategy is implantation of a biodegradable scaffold and filling the porous architecture with either adipose tissue from a fat grafting procedure and/or seeding it with adipocyte precursor cells. The goal is to regenerate adipose tissue that is sustained and mimics the shape, size, and feel of the patient’s native breast. Vascularization remains a significant barrier to generation of clinically relevant volumes of adipose tissue. However, numerous tissue engineering and regenerative medicine approaches have been proposed to improve this. This article reviews advancements in breast tissue engineering as well as presents the challenges and considerations that needs to be made when translating proposed approaches to clinical practice.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.